Key regions: Australia, United States, India, Europe, China
The Digestive & Intestinal Remedies (Pharmacies) market in Northern Europe is experiencing significant growth due to changing customer preferences and trends in the market. Customer preferences in Northern Europe have shifted towards natural and organic remedies for digestive and intestinal issues. Consumers are increasingly seeking products that are free from artificial ingredients and chemicals, and are opting for natural alternatives such as herbal remedies and probiotics. This shift in preferences is driven by a growing awareness of the potential side effects of conventional medications and a desire for more holistic approaches to health and wellness. Trends in the market also play a role in the development of the Digestive & Intestinal Remedies market in Northern Europe. One major trend is the increasing prevalence of digestive and intestinal issues, such as irritable bowel syndrome (IBS) and acid reflux, among the population. This has led to a higher demand for remedies that can alleviate symptoms and provide relief. Additionally, the aging population in Northern Europe is more prone to digestive and intestinal problems, further driving the demand for these remedies. Local special circumstances in Northern Europe also contribute to the growth of the Digestive & Intestinal Remedies market. The region has a strong healthcare system and a high level of awareness about the importance of digestive health. This has led to a greater emphasis on prevention and self-care, with consumers actively seeking out remedies to maintain their digestive health. Pharmacies in Northern Europe are well-positioned to cater to this demand, as they offer a wide range of over-the-counter remedies and have knowledgeable staff who can provide advice and recommendations. Underlying macroeconomic factors also play a role in the development of the market. Northern Europe has a high disposable income and a strong purchasing power, allowing consumers to afford premium products and invest in their health. Additionally, the region has a well-developed retail infrastructure, with a large number of pharmacies and healthcare stores that stock a wide range of digestive and intestinal remedies. This accessibility and availability of products further contribute to the growth of the market. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Northern Europe is experiencing growth due to changing customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The shift towards natural and organic remedies, increasing prevalence of digestive and intestinal issues, emphasis on prevention and self-care, and strong healthcare system and retail infrastructure all contribute to the development of the market in this region.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
